- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Rachel Jimenez: Risk, Nature of Cardiac Toxicity in Breast Cancer Is Variable
Rachel Jimenez, MD, radiation oncologist at Massachusetts General Hospital, outlines the prevalence of cardiac toxicity, as well as the short-term and long-term impacts.
Rachel Jimenez, MD, radiation oncologist at Massachusetts General Hospital, outlines the prevalence of cardiac toxicity, as well as the short-term and long-term impacts.
Transcript
How prevalent is cardiac toxicity in breast cancer, and what are some examples of the short-term versus long-term impact?
The risk of cardiac toxicity and the nature of cardiac toxicity in breast cancer is quite variable and it depends a lot on the patient’s baseline risk factors as well as what specific therapies they receive. So, we see different types of short- and long-term side effects based on the specific type of therapy that a patient receives for their breast cancer.
For example, as a radiation oncologist, my patients will receive radiotherapy that could expose the heart to radiation, and studies have suggested that in the short term that can cause pericarditis or other pericardial diseases and in the long term could cause coronary artery disease or heart failure.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
